202 related articles for article (PubMed ID: 38201229)
21. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Analyses Reveal the Role of Alpha-2-Macroglobulin in Canine Osteosarcoma Cell Migration.
Wilk SS; Michalak K; Owczarek EP; Winiarczyk S; Zabielska-Koczywąs KA
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612805
[TBL] [Abstract][Full Text] [Related]
23. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
24. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
25. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.
Gola C; Giannuzzi D; Rinaldi A; Iussich S; Modesto P; Morello E; Buracco P; Aresu L; De Maria R
Front Vet Sci; 2021; 8():666838. PubMed ID: 34079834
[TBL] [Abstract][Full Text] [Related]
26. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract][Full Text] [Related]
27. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
[TBL] [Abstract][Full Text] [Related]
28.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
29. The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas.
Gola C; Licenziato L; Accornero P; Iussich S; Morello E; Buracco P; Modesto P; Aresu L; De Maria R
Vet Comp Oncol; 2022 Dec; 20(4):890-900. PubMed ID: 36054794
[TBL] [Abstract][Full Text] [Related]
30. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Nam A; Kim T; Li Q; Rebhun RB; Youn HY; Seo KW
J Vet Med Sci; 2019 Dec; 81(12):1722-1729. PubMed ID: 31645504
[TBL] [Abstract][Full Text] [Related]
31. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
Silva G; Aboussekhra A
Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.
Russell DS; Jaworski L; Kisseberth WC
J Vet Diagn Invest; 2018 Jul; 30(4):504-509. PubMed ID: 29629647
[TBL] [Abstract][Full Text] [Related]
33. Genomic instability and telomere fusion of canine osteosarcoma cells.
Maeda J; Yurkon CR; Fujisawa H; Kaneko M; Genet SC; Roybal EJ; Rota GW; Saffer ER; Rose BJ; Hanneman WH; Thamm DH; Kato TA
PLoS One; 2012; 7(8):e43355. PubMed ID: 22916246
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines.
Yang YT; Yuzbasiyan-Gurkan V
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012610
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
Sottnik JL; Thamm DH
Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
[TBL] [Abstract][Full Text] [Related]
38. Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.
Lutful Kabir FM; DeInnocentes P; Bird AC; Bird RC
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):519-530. PubMed ID: 34014456
[TBL] [Abstract][Full Text] [Related]
39. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms of Canine Osteosarcoma Metastasis.
Wilk SS; Zabielska-Koczywąs KA
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]